References:
1) Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, Huang J, He N, Yu H,
Lin X, Wei S, Wu T. Association of Public Health Interventions With the
Epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA. 2020;
323:1-9.
2) Kotecha RS. Challenges posed by COVID-19 to children with cancer.
Lancet Oncol. 2020 May;21(5):e235.
3) Sullivan M, Bouffet E, Rodriguez-Galindo C, Luna-Fineman S, Khan
MS, Kearns P, Hawkins DS, Challinor J, Morrissey L, Fuchs J, Marcus K,
Balduzzi A, Basset-Salom L, Caniza M, Baker JN, Kebudi R, Hessissen L,
Sullivan R, Pritchard-Jones K. The COVID-19 pandemic: A rapid global
response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC,
IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer. 2020 May
13:e28409.
4) de Rojas T, Pérez-Martínez A, Cela E, Baragaño M, Galán V, Mata
C, Peretó A, Madero L COVID-19 infection in children and adolescents
with cancer in Madrid. Pediatr Blood Cancer. 2020 May 8:e28397.
5) Terenziani M, Massimino M, Biassoni V, Casanova M, Chiaravalli S,
Ferrari A, Luksch R, Meazza C, Podda M, Schiavello E, Spreafico
F.SARS-CoV-2 disease and children under treatment for cancer.Pediatr
Blood Cancer. 2020 May 6:e28346.
6) Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID19
in Children With Cancer in New York City. JAMA Oncol. 2020 May
13:e202028.
7) André N, Rouger-Gaudichon J, Brethon B, Phulpin A, Thébault É,
Pertuisel S, Gandemer V. COVID-19 in pediatric oncology from French
pediatric oncology and hematology centers: High risk of severe forms?
Pediatr Blood Cancer. 2020 May 8:e28392
Acknowledgement : None
Conflict of interest : None